Alzheimer's disease risk disclosure

BEHAVIORAL2 trials

Sponsors

Brigham and Women's Hospital

Conditions

Alzheimer DiseaseAmyloid Beta-PeptidesEducationMild Cognitive ImpairmentNeuroimagingNeuropsychological TestsRisk Assessment

Unknown Phase

Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV

CompletedNCT01434667

Brigham and Women's HospitalMild Cognitive Impairment

Start: 2010-01-31End: 2014-07-31Updated: 2018-10-23

Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)

CompletedNCT02959489

Brigham and Women's HospitalAlzheimer Disease, Amyloid Beta-Peptides, Education +3

Start: 2016-11-30End: 2021-04-29Updated: 2024-04-02

Related Papers

Study partner perspectives on disclosure of amyloid PET scan results

Alzheimer s & Dementia2020-12-011 citations